GlassScriptPhysician profile
Michael S Oldenburg
NPI 1770847683
$8,073.03
in general payments reported to CMS, 2019-2025
11 companies · $2,002 in 2025
The $2,002 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,652 · 2020: $451 · 2021: $469 · 2022: $104 · 2023: $194 · 2024: $202 · 2025: $2,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,598 · Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,597.57 |
| Food and Beverage | $800.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $3,495.05 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Med-El Corporation | $2,005.30 | 2023-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Bone Anchored Solutions Ab | $1,476.89 | 2019 | |
| Aerin Medical INC. | $411.50 | 2020-2023 | |
| Covidien LP | $325.00 | 2019 | |
| Acclarent, INC | $216.23 | 2021-2022 | |
| Stryker Corporation | $42.84 | 2019 | |
| Glaxosmithkline, LLC. | $33.22 | 2023 | Nucala |
| Intersect Ent, INC. | $31.14 | 2019 | |
| Intuitive Surgical, INC. | $22.40 | 2024 | |
| Medtronic, INC. | $13.46 | 2023 | Pteye Parathyroid Detection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oldenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.